Arbutus Biopharma (ABUS) Other Non Operating Income (2013 - 2026)
Arbutus Biopharma's (ABUS) quarterly Other Non Operating Income came in at -$11000.0 in Q1 2026, down 375.0% year-on-year from $4000.0 in Q1 2025, and down 1200.0% quarter-over-quarter from $1000.0 in Q4 2025.
Arbutus Biopharma (ABUS) Other Non Operating Income (2013 - 2026) Analysis & Trends
Arbutus Biopharma has disclosed Other Non Operating Income across 14 years of filings, most recently posting -$11000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$11000.0, down 375.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1000.0 (up 96.88% YoY), and the FY2025 annual result was $14000.0, up 128.57% from the prior year.
- Other Non Operating Income came in at -$11000.0 for Q1 2026 at Arbutus Biopharma, down from $1000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $21000.0 in Q2 2025 to a low of -$33000.0 in Q4 2024.
- The 5-year median for Other Non Operating Income is $1000.0 (2023), against an average of -$2687.5.
- Across the five-year window, Other Non Operating Income soared 450.0% in 2023 and slumped 900.0% in 2024, its largest moves.
- Arbutus Biopharma's Other Non Operating Income stood at -$4000.0 in 2022, then jumped by 450.0% to $14000.0 in 2023, then sank by 335.71% to -$33000.0 in 2024, then surged by 103.03% to $1000.0 in 2025, then plunged by 1200.0% to -$11000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$11000.0 (Q1 2026), $1000.0 (Q4 2025), and -$12000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | 28,000.00 |